Cowen Financial Products LLC 13D and 13G filings for PMV Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-01-24 2:44 pm Sale |
2022-12-30 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Cowen Financial Products LLC | 1,500,326 3.280% |
-799,674 (-34.77%) |
Filing |
| 2022-01-19 3:43 pm Purchase |
2022-01-14 | 13G | PMV Pharmaceuticals, Inc. PMVP |
Cowen Financial Products LLC | 2,300,000 5.070% |
2,300,000 (New Position) |
Filing |